指南与共识甲状腺疾病性腺与生殖内分泌

2017年美国甲状腺协会妊娠及产后甲状腺疾病诊断与管理指南

2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.
指南 / 共识 · Thyroid · 2017-01-01

该指南由美国甲状腺协会(ATA)制定,基于2011年版更新,采用美国医师学会指南分级系统对证据进行严格评估并给出推荐强度,涵盖妊娠期甲状腺功能检查解读、碘营养、甲状腺自身抗体与妊娠并发症、不孕女性甲状腺问题、妊娠期甲减与甲亢、甲状腺结节与癌症、胎儿与新生儿考虑、哺乳期甲状腺疾病及筛查等,为临床决策提供循证推荐。

要点

  • 指南涵盖妊娠期甲状腺功能检查解读、碘营养、甲状腺自身抗体与妊娠并发症等推荐。
  • 采用美国医师学会指南分级系统评估证据和推荐强度。
  • 推荐涉及妊娠期甲减、甲亢、甲状腺结节与癌症、胎儿新生儿考虑及筛查。

核心结论

  • 制定了基于证据的推荐,用于指导妊娠期和产后甲状腺疾病管理的临床决策。
  • 所有医疗必须个体化,这些推荐提供了最佳治疗模式。

研究设计与样本

  • 美国甲状腺协会(ATA)制定,基于先前版本、利益相关者意见和工作组成员意见确定临床问题。
  • 工作组接受知识合成方法培训,包括电子数据库检索、文献筛选和严格评估,仅纳入已发表的英文文献。
  • 使用美国医师学会指南分级系统评估证据质量和推荐强度。

主要发现

  • 修订后的指南包括妊娠期甲状腺功能检查解读、碘营养、甲状腺自身抗体与妊娠并发症、不孕女性甲状腺考虑、妊娠期甲减、妊娠期甲亢、孕妇甲状腺结节与癌症、胎儿与新生儿考虑、哺乳期甲状腺疾病、妊娠期甲状腺功能障碍筛查及未来研究方向等推荐。

关键数值与推荐

  • 使用美国医师学会指南分级系统评估证据和推荐强度。
  • 推荐涉及甲状腺功能检查解读、碘营养、甲状腺自身抗体与妊娠并发症、不孕女性甲状腺考虑、妊娠期甲减、妊娠期甲亢、甲状腺结节与癌症、胎儿与新生儿考虑、哺乳期甲状腺疾病及筛查。

临床怎么用

  • 推荐用于指导妊娠期和产后甲状腺疾病管理的临床决策。
  • 所有医疗必须个体化,推荐提供了最佳治疗模式。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thyroid disease in pregnancy is a common clinical problem. Since the guidelines for the management of these disorders by the American Thyroid Association (ATA) were first published in 2011, significant clinical and scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid disease in women during pregnancy, preconception, and the postpartum period. METHODS: The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles were eligible for inclusion. The American College of Physicians Guideline Grading System was used for critical appraisal of evidence and grading strength of recommendations. The guideline task force had complete editorial independence from the ATA. Competing interests of guideline task force members were regularly updated, managed, and communicated to the ATA and task force members. RESULTS: The revised guidelines for the management of thyroid disease in pregnancy include recommendations regarding the interpretation of thyroid function tests in pregnancy, iodine nutrition, thyroid autoantibodies and pregnancy complications, thyroid considerations in infertile women, hypothyroidism in pregnancy, thyrotoxicosis in pregnancy, thyroid nodules and cancer in pregnant women, fetal and neonatal considerations, thyroid disease and lactation, screening for thyroid dysfunction in pregnancy, and directions for future research. CONCLUSIONS: We have developed evidence-based recommendations to inform clinical decision-making in the management of thyroid disease in pregnant and postpartum women. While all care must be individualized, such recommendations provide, in our opinion, optimal care paradigms for patients with these disorders.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017. PMID: 28056690. doi:10.1089/thy.2016.0457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。